Cargando…
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides
The therapeutic and research potentials of oligonucleotides (ONs) have been hampered in part by their inability to effectively escape endosomal compartments to reach their cytosolic and nuclear targets. Splice-switching ONs (SSOs) can be used with endosomolytic small molecule compounds to increase f...
Autores principales: | Bost, Jeremy P., Ojansivu, Miina, Munson, Michael J., Wesén, Emelie, Gallud, Audrey, Gupta, Dhanu, Gustafsson, Oskar, Saher, Osama, Rädler, Julia, Higgins, Stuart G., Lehto, Taavi, Holme, Margaret N., Dahlén, Anders, Engkvist, Ola, Strömstedt, Per-Erik, Andersson, Shalini, Edvard Smith, C. I., Stevens, Molly M., Esbjörner, Elin K., Collén, Anna, El Andaloussi, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888659/ https://www.ncbi.nlm.nih.gov/pubmed/35233031 http://dx.doi.org/10.1038/s42003-022-03132-2 |
Ejemplares similares
-
Delivery
of Oligonucleotide Therapeutics: Chemical
Modifications, Lipid Nanoparticles, and Extracellular Vesicles
por: Bost, Jeremy P., et al.
Publicado: (2021) -
Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo
por: Bazaz, Safa, et al.
Publicado: (2021) -
Efficient Peptide-Mediated In Vitro Delivery of Cas9 RNP
por: Gustafsson, Oskar, et al.
Publicado: (2021) -
Sugar and Polymer Excipients Enhance Uptake and Splice-Switching Activity of Peptide-Dendrimer/Lipid/Oligonucleotide Formulations
por: Saher, Osama, et al.
Publicado: (2019) -
Fluorescent base analogues in gapmers enable stealth labeling of antisense oligonucleotide therapeutics
por: Nilsson, Jesper R., et al.
Publicado: (2021)